Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial - NBC News

Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial  NBC NewsModerna's mRNA flu vaccine outperforms standard shot in late-stage trial  ReutersModerna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010  Rutland HeraldModerna’s mRNA flu vaccine more effective than current SOC  Clinical Trials ArenaModerna Inc. (MRNA) Initiates Phase 3 Trial for mRNA H5 Pandemic Influenza Vaccine, Expanding Pipeline Upside - Profit  Newser